ClinicalTrials.gg
Sign In

Gastrointestinal Neoplasms clinical trials

The registry lists 696 studies for Gastrointestinal Neoplasms across more than 10 countries. 210 are recruiting or about to start. 314 of them are mainly about Gastrointestinal Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 18 narrower conditions too, such as Colorectal Neoplasms: 15,626 studies, 4,281 open.

ClinicalTrials.gov finds 23,389 studies for Gastrointestinal Neoplasms. How that becomes 694 here

This page counts the studies the registry files under Gastrointestinal Neoplasms, and those it files under no condition that list Gastrointestinal Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 23,389Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −13,850Filed under a narrower condition, counted on its own pageColorectal Neoplasms 5,982 · Stomach Neoplasms 2,762 · Colonic Neoplasms 1,384 · Rectal Neoplasms 1,285 · Esophageal Neoplasms 1,206 · Esophageal Squamous Cell Carcinoma 442 · 12 more
  3. −21List Gastrointestinal Neoplasms as a condition, but the registry did not file them under itMost often written as “Advanced Gastrointestinal Cancer” (5), “Gastrointestinal Cancer Metastatic” (3), and “Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition” (1). The registry filed 17 of them under no condition at all, and the others under other conditions only, most often Carcinoma, Hepatocellular (1) and Neuroendocrine Tumors (1).
  4. −8,824Match it another way41 name it in the title, 2 in a keyword, and 8,781 by a synonym or other text the search reads.
  5. 694The count on this page

Get an email when these change. Save the Gastrointestinal Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
282
Recruiting
160
Status unknown
79
Terminated
56
Active, not recruiting
44
Not yet recruiting
39

Phase

Phase 2
160
Phase 1
137
Phase 3
38
Phase 4
12
Early Phase 1
11

Where

United States
316
China
109
France
63
Canada
38
Spain
35
Korea, Republic of
34

Who runs them

M.D. Anderson Cancer Center (25) · National Cancer Institute (NCI) (23) · Dana-Farber Cancer Institute (12) · Baylor College of Medicine (9) · Revolution Medicines, Inc. (8) · GlaxoSmithKline (8) · Abramson Cancer Center at Penn Medicine (7) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (7)

What is being tested here

Drugs under test in Gastrointestinal Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
IDRX-42617
Daraxonrasib404
Irinotecan3311
Oxaliplatin3210
Fluorouracil2110
Capecitabine217
Pafolacianine202
Zoldonrasib202
Docetaxel212
Pemigatinib202

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 11 open · Immune checkpoint inhibitors 6 open · Antimetabolites 4 open · Angiogenesis inhibitors 2 open · Antibody-drug conjugates (ADCs) 2 open

Coming up

12phase 3 studies under way
85studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 160 Gastrointestinal Neoplasms studies recruiting now, 122 (76%) set no upper age limit and 18 (11%) stop at 75 or younger. 8 (5%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 9 (6%) take healthy volunteers.

Recruiting studies that take each age, of 160
AgeWomenMen
107 (4%)7 (4%)
18148 (93%)148 (93%)
30152 (95%)152 (95%)
40152 (95%)152 (95%)
50154 (96%)154 (96%)
65159 (99%)159 (99%)
75154 (96%)154 (96%)
85136 (85%)136 (85%)

Across all 696 studies, recruiting or not: 13% stop at 75 or younger and 2% at 65; 5% take children; 1% are for women only and <1% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Gastrointestinal Neoplasms studies take

Of 55 phase 2 interventional studies under Gastrointestinal Neoplasms, half reached primary completion within 44 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 142 mo35–71 · 49 studies——
Phase 1/264 mo42–… · 36 studies——
Phase 244 mo32–73 · 55 studies——
Interventional, no phase36 mo17–71 · 163 studies—39 mo19–71 · 153 studies
Observational43 mo16–102 · 88 studies—43 mo13–102 · 79 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted2

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 696. Browse all 696 → or search them.